Show
Sort by
-
Glofitamab monotherapy induces high complete response rates in patients with heavily pretreated Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL)
(2023) ONCOLOGY RESEARCH AND TREATMENT. In Oncology Research and Treatment 46(Supplement 5). p.23-24 -
Long-term clinical outcomes and correlative efficacy analyses in patients (Pts) with relapsed/refractory (r/r) follicular lymphoma (FL) treated with tisagenlecleucel in the ELARA Trial
(2023) ONCOLOGY RESEARCH AND TREATMENT. In Oncology Research and Treatment 46(Supplement 5). p.306-308 -
Glofitamab in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and >= 2 prior lines of therapy : key results of the phase-II expansion
(2022) ONCOLOGY RESEARCH AND TREATMENT. In Oncology Research and Treatment 45(Supplement 2). p.50-51 -
Non-invasive cardiovascular risk assessment in prepubertal children
-
The positive predictive value of high-grade squamous intraepithelial lesion on cytology for the histological diagnosis of cervical intraepithelial neoplasia 2 or higher : a systematic review
-
Cross-sectional and longitudinal risk of metabolic syndrome and inflammation in European children : the IDEFICS study
(2019) ANNALS OF NUTRITION AND METABOLISM. In Annals of Nutrition and Metabolism 75(Supplement 2). p.65-65 -
The place of large pore membranes in the treatment portfolio of patients on hemodialysis
-
The role of general practitioners and family physicians in the management of multimorbidity
(2015) Management of comorbidity of mental and physical illness. In Key Issues in Mental Health 179. p.129-136 -
Food-based diet quality indices : concepts, applications & validity
(2015) ANNALS OF NUTRITION AND METABOLISM. In Annals of Nutrition and Metabolism 67(Supplement 1). p.195-195 -
Managing the risk of germ cell tumourigenesis in disorders of sex development patients